Shay Shemesh - Sep 2, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Dev. & Ops. Officer
Signature
/s/ Shay Shemesh
Stock symbol
NVCT
Transactions as of
Sep 2, 2022
Transactions value $
$3,357
Form type
4
Date filed
9/6/2022, 08:00 AM
Previous filing
Sep 2, 2022
Next filing
Sep 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $3.36K +404 +0.03% $8.31 1.24M Sep 2, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.29 to $8.34. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Includes 48,399 shares of restricted stock and 60,000 restricted stock units.